Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0620919970290040203
Experimental & Molecular Medicine
1997 Volume.29 No. 4 p.203 ~ p.208
Stimulation of c-myc protooncogene expression by transforming growth factor ¥á in human ovarian cancer cells
Hae Young Park/Jeong Youn Choi
Young Sook Hong/Hae Young Park
Abstract
To investigate whether transforming growth factor ¥á (TGF ¥á) treatment of human ovarian cancer cells was associated with the induction of c-myc protooncogene, the expression of this gene in NIH:OVCAR-3 cells was examined. TGF ¥á induced increase in c-myc mRNA level, with a peak after 1 h of treatment; this stimulation was dose-dependent, with an optimal concentration of 5 ng/ml TGF ¥á. Its primary action is probably at the transcription level since the half-life of c-myc mRNA measured in the presence of actinomycin D was not modified by TGF ¥á treatment. In addition, TGF ¥á stimulation of c-myc mRNA did not require protein synthesis since it was not suppressed by cycloheximide treatment. Antisense phosphorothioate oligonucleotide to c-myc specifically inhibited the TGF ¥á-stimulated c-Myc protein expression and growth of NIH:OVCAR-3 cells. Our results indicate that induction of c-myc expression by TGF ¥á plays an important role in the growth of NIH:OVCAR-3 cells.
KEYWORD
c-myc, ovarian cancer cells, TGF¥á,
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø